NextCure, Inc. Operating Income Loss

• NextCure, Inc. showed an increase of +3.6% in Operating Income Loss from 2024 to 2025.
• This data is from NextCure, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), NextCure, Inc.'s Operating Income Loss has declined by 148.4%.
• Historical annual values: Fiscal year 2025: -$57.62 million | Fiscal year 2024: -$59.75 million | Fiscal year 2023: -$67.64 million | Fiscal year 2022: -$75.91 million | Fiscal year 2021: -$70.77 million | Fiscal year 2020: -$41.23 million | Fiscal year 2019: -$37.48 million | Fiscal year 2018: -$23.20 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026